AIM
AXSM icon

Aigen Investment Management’s Axsome Therapeutics AXSM Stock Holding History

Aigen Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,063
Closed -$424K – 790
2025
Q2 		$424K Sell
4,063
-2,671
-40% -$283K 0.06% 439
2025
Q1 		$785K Buy
6,734
+2,071
+44% +$236K 0.13% 251
2024
Q4 		$395K Buy
+4,663
New +$429K 0.07% 403
2024
Q1 		– Sell
-3,866
Closed -$308K – 672
2023
Q4 		$308K Buy
+3,866
New +$258K 0.05% 477
2023
Q1 		– Sell
-3,046
Closed -$235K – 617
2022
Q4 		$235K Buy
+3,046
New +$182K 0.03% 418

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return